Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;138(3 Suppl):18S-28S.
doi: 10.1097/PRS.0000000000002682.

Biology and Biomarkers for Wound Healing

Linsey E Lindley  1   2 , Olivera Stojadinovic  1   2 , Irena Pastar  1   2 , Marjana Tomic-Canic  1   2
Affiliations
Review

Biology and Biomarkers for Wound Healing

Linsey E Lindley et al. Plast Reconstr Surg. 2016 Sep.

Abstract

Background: As the population grows older, the incidence and prevalence of conditions that lead to a predisposition for poor wound healing also increase. Ultimately, this increase in nonhealing wounds has led to significant morbidity and mortality with subsequent huge economic ramifications. Therefore, understanding specific molecular mechanisms underlying aberrant wound healing is of great importance. It has and will continue to be the leading pathway to the discovery of therapeutic targets, as well as diagnostic molecular biomarkers. Biomarkers may help identify and stratify subsets of nonhealing patients for whom biomarker-guided approaches may aid in healing.

Methods: A series of literature searches were performed using Medline, PubMed, Cochrane Library, and Internet searches.

Results: Currently, biomarkers are being identified using biomaterials sourced locally from human wounds and/or systemically using high-throughput "omics" modalities (genomic, proteomic, lipidomic, and metabolomic analysis). In this review, we highlight the current status of clinically applicable biomarkers and propose multiple steps in validation and implementation spectrum, including those measured in tissue specimens, for example, β-catenin and c-myc, wound fluid, matrix metalloproteinases and interleukins, swabs, wound microbiota, and serum, for example, procalcitonin and matrix metalloproteinases.

Conclusions: Identification of numerous potential biomarkers using different avenues of sample collection and molecular approaches is currently underway. A focus on simplicity and consistent implementation of these biomarkers, as well as an emphasis on efficacious follow-up therapeutics, is necessary for transition of this technology to clinically feasible point-of-care applications.

PubMed Disclaimer

Conflict of interest statement

Authors declare no conflict of interest.

Figures

Figure 1
Figure 1. The future
The flow chart shows potential use of various types of biomarkers to personalize treatment approach in patients with chronic wounds.
Figure 2
Figure 2. The long road of discovery and development of biomarkers
Steps in development of biomarker start from biomarker discovery, development of specific assay to be used in clinic and a final biomarker validation in multicenter clinical trials before it becomes available for use as a guiding tool by physicians in clinics.
Figure 3
Figure 3. Biomarker-based guidance to debridement
Possible use of biomarkers as an indicator for a debridement margin e.g. how far wound care practitioner should debride a chronic wound.
See this image and copyright information in PMC

Comment in

References

    1. Sen CK, Gordillo GM, Roy S, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2009 Nov-Dec;17(6):763–771. - PMC - PubMed
    1. Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014 Dec 3;6(265):265sr266. - PMC - PubMed
    1. Brem H, Stojadinovic O, Diegelmann RF, et al. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med. 2007 Jan-Feb;13(1–2):30–39. - PMC - PubMed
    1. Armstrong DG, Wrobel J, Robbins JM. Guest Editorial: are diabetes-related wounds and amputations worse than cancer? Int Wound J. 2007 Dec;4(4):286–287. - PubMed
    1. Aulivola B, Hile CN, Hamdan AD, et al. Major lower extremity amputation: outcome of a modern series. Arch Surg. 2004 Apr;139(4):395–399. discussion 399. - PubMed

MeSH terms